QS Pharma gets nod from EMA for commercial manufacture
The European Medicines Agency (EMA) has approved QS Pharma to manufacture medicinal products for commercial use in Europe.
Archives for June 26, 2017
CRO Altasciences sees opportunity in fragmented early clinical development space
Altasciences Company has been acquired by Audax Private Equity as it looks to expand in the fragmented early clinical development space.
Fagron and Advanced Pharma pull drugs made at Pfizer's Rocky Mount site
Fagron Sterile Services and Advanced Pharma have recalled lots of injectable drugs made at Pfizer’s Rocky Mount facility in North Carolina.
Biogen's drug discovery program gets quantum boost from improved molecular design
Biogen and Accenture Labs have collaborated to develop a quantum-enabled molecular comparison application to accelerate drug discovery and ultimately, time to clinic.
Open for comment: US FDA confirms backing for continuous manufacturing and calls for industry input
The US Food and Drug Administration (FDA) has called for drug industry feedback on continuous manufacturing.
Grace to start making fluorinated drug intermediates with tech from Valliscor
W.R Grace & Co has announced its intention to start making fluorinated pharmaceutical intermediates with technology obtained from Valliscor Llc.
Lonza’s $5.5bn Capsugel takeover cleared by regulators
Lonza expects to complete its $5.5bn (€5.2bn) takeover of Capsugel SA in the next few days having secured approval from competition authorities around the world.